| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ANKRD12_0000200 | Intergenic-Exon | chr18:9136751-9279642 | chr18:9136753-9279644 | 250 nt | 0.4000 |
| hsa_ANKRD12_0003500 | Exon-Exon | chr18:9182380-9195696 | chr18:9182382-9195698 | 286 nt | 0.3811 |
| hsa_ANKRD12_0003600 | Intron-Exon-Intron | chr18:9182380-9200642 | chr18:9182382-9200644 | 250 nt | 0.3320 |
| hsa_ANKRD12_0003700 | Exon-Exon | chr18:9182380-9204542 | chr18:9182382-9204544 | 355 nt | 0.3859 |
| hsa_ANKRD12_0003800 | Exon-Exon | chr18:9182380-9208795 | chr18:9182382-9208797 | 496 nt | 0.3891 |
| hsa_ANKRD12_0003900 | Exon-Exon | chr18:9182380-9208801 | chr18:9182382-9208803 | 502 nt | 0.3924 |
| hsa_ANKRD12_0004000 | Exon-Exon | chr18:9182380-9211782 | chr18:9182382-9211784 | 703 nt | 0.3869 |
| hsa_ANKRD12_0004100 | Exon-Exon | chr18:9182380-9216898 | chr18:9182382-9216900 | 846 nt | 0.3948 |
| hsa_ANKRD12_0004200 | Exon-Exon | chr18:9182380-9221963 | chr18:9182382-9221965 | 960 nt | 0.3990 |
| hsa_ANKRD12_0004300 | Exon-Exon | chr18:9182380-9221997 | chr18:9182382-9221999 | 994 nt | 0.3984 |
A study in humans demonstrated that circANKRD12 circANKRD12 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, with RT-qPCR validation showing high diagnostic efficacy as reflected by an area under the curve of 0.7819 in receiver operating characteristic analysis [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in humans demonstrated that the circANKRD12 was identified as a differentially expressed circular RNA in the peripheral blood of myocardial infarction patients and was confirmed in an AC16 cell model [Tian et al. DOI: 10.3390/molecules26041155].